7.3618
price up icon4.10%   0.2918
 
loading

Mind Medicine Inc Borsa (MNMD) Ultime notizie

Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com South Africa

pulisher
Investing.com South Africa

Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Mind Medicine CEO Robert Barrow sells shares worth over $113k - Investing.com India

pulisher
Investing.com India

MindMed's chief medical officer sells shares worth nearly $50k By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Dan Karlin Sells 6,925 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat

pulisher
MarketBeat

Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com

pulisher
Investing.com

Brokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Target Price at $20.00 - MarketBeat

pulisher
MarketBeat

MindMed Advances GAD Treatment into Phase 3 Trials - TipRanks.com - TipRanks

pulisher
TipRanks

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

pulisher
Defense World

Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - MSN

pulisher
MSN

Mind Medicine (MindMed) (NASDAQ:MNMD) Receives Overweight Rating from Cantor Fitzgerald - Defense World

pulisher
Defense World

Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $100.00 at Mizuho - Defense World

pulisher
Defense World

Mind Medicine (MindMed) (NASDAQ:MNMD) Receives Overweight Rating from Cantor Fitzgerald - Defense World

pulisher
Defense World

Mind Medicine (MindMed)'s (MNMD) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

pulisher
MarketBeat

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - StockTitan

pulisher
StockTitan

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - Business Wire

pulisher
Business Wire

MindMed advances LSD-based drug for GAD to Phase 3 trials - Investing.com India

pulisher
Investing.com India

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder ... - Business Wire

pulisher
Business Wire

Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - MSN

pulisher
MSN

3 Top Canadian Psychedelic Stocks for June 2024 - Stocktrades.ca

pulisher
Stocktrades.ca

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 - InvestorPlace

pulisher
InvestorPlace

Is Mind Medicine Inc (MNMD) a threat to investors? – US Post News - US Post News

pulisher
US Post News

Mind Medicine Inc (MNMD) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily

pulisher
Knox Daily

(MNMD) Trading Signals - Stock Traders Daily

pulisher
Stock Traders Daily

Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - Yahoo Finance

pulisher
Yahoo Finance

Mind Medicine Inc [MNMD] Records 200-Day SMA of $5.50 – Knox Daily - Knox Daily

pulisher
Knox Daily

7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money

pulisher
U.S News & World Report Money

7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money

pulisher
U.S News & World Report Money

7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money

pulisher
U.S News & World Report Money

7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money

pulisher
U.S News & World Report Money

Robert W. Baird analysts initates an Outperform rating for Mind Medicine Inc (MNMD) – Knox Daily - Knox Daily

pulisher
Knox Daily

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - MarketBeat

pulisher
MarketBeat

A History of Outperforming Analyst Forecasts and Beating the Odds: Mind Medicine Inc (MNMD) – Sete News - SETE News

pulisher
SETE News

Mind Medicine Inc: Navigating Market Fluctuations with a 221.62M Market Cap - The InvestChronicle

pulisher
The InvestChronicle

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 7.3% - MarketBeat

pulisher
MarketBeat

It would be worthwhile to take a closer look at Mind Medicine Inc (MNMD) – US Post News - US Post News

pulisher
US Post News

MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health ... - Marketscreener.com

pulisher
Marketscreener.com

Why Earnings Season Could Be Great for Mind Medicine (MNMD) - Yahoo Movies UK

pulisher
Yahoo Movies UK

Mind Medicine Inc [NASDAQ: MNMD] Sees Decrease in Stock Value – Knox Daily - Knox Daily

pulisher
Knox Daily

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as ... - Yahoo Finance

pulisher
Yahoo Finance

Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Down 2.8% - Defense World

pulisher
Defense World

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as ... - Yahoo Finance

pulisher
Yahoo Finance

A better buy-in window may exist right now for Mind Medicine Inc (MNMD) – Sete News - SETE News

pulisher
SETE News

Mind Medicine (MindMed) (NASDAQ:MNMD) Receives “Outperform” Rating from Royal Bank of Canada - Defense World

pulisher
Defense World

Mind Medicine - Osler, Hoskin & Harcourt LLP

pulisher
Osler, Hoskin & Harcourt LLP

Scotia Capital Inc. Takes $441000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World

pulisher
Defense World

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $8.25 - MarketBeat

pulisher
MarketBeat

MNMD’s Market Whiplash: 93.99% YTD Rise, -22.99% Plunge in 30 Days - The InvestChronicle

pulisher
The InvestChronicle
$146.84
price down icon 2.64%
$85.02
price up icon 0.02%
$25.72
price down icon 0.25%
$84.20
price down icon 2.90%
$447.85
price down icon 0.91%
$247.90
price up icon 3.32%
Capitalizzazione:     |  Volume (24 ore):